Literature DB >> 6802325

Turnover rate of anti-D IgG injected during pregnancy.

J Eklund, M Hermann, H Kjellman, P Pohja.   

Abstract

Anti-D IgG was injected into 15 Rh-negative women in the 28th week of gestation and into three non-pregnant women. The uptake of anti-D after the intramuscular injections was calculated by measuring the concentration of antibody in the plasma with an autoanalyser. The biological half life and the catabolic rate of anti-D IgG were calculated according to a compartmental model. The recovery in vivo of anti-D was an average 24% in the non-pregnant women and 21% in the pregnant women. The half life of anti-D were 24 and 21 days, respectively. With a dose of 125 micrograms the plasma anti-D concentration was less than 1 ng/ml at about 10 weeks after the injection. With double the dose the concentration at delivery was at least 1 ng/ml. Although 250 micrograms of anti-D IgG seems to be effective when given in the 28th weeks of gestation, the great individual variations in uptake and recovery rates will lead to occasional cases of Rh-immunisation during pregnancy despite all routine regimens.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6802325      PMCID: PMC1496261          DOI: 10.1136/bmj.284.6319.854

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  12 in total

1.  [Behavior of intramuscular, intravenous and oral gamma globulin].

Authors:  R MARTIN DU PAN; J J SCHEIDEGGER; P WENGER; B KOECHLI; J ROUX
Journal:  Blut       Date:  1959-04

2.  Metabolic heterogeneity of human gamma-globulin.

Authors:  S COHEN; T FREEMAN
Journal:  Biochem J       Date:  1960-09       Impact factor: 3.857

3.  Uptake of IgG after intramuscular and subcutaneous injection.

Authors:  G N Smith; B Griffiths; D Mollison; P L Mollison
Journal:  Lancet       Date:  1972-06-03       Impact factor: 79.321

4.  The anti-D content of IgG preparations for use in the prevention of Rh haemolytic disease.

Authors:  N C Hughes-Jones; M Stevenson
Journal:  Vox Sang       Date:  1968       Impact factor: 2.144

5.  In vivo behaviour of gamma globulin preparations.

Authors:  A Morell; B Schürch; D Ryser; F Hofer; F Skvaril; S Barandun
Journal:  Vox Sang       Date:  1980       Impact factor: 2.144

6.  Rh isoimmunization during pregnancy: antenatal prophylaxis.

Authors:  J M Bowman; B Chown; M Lewis; J M Pollock
Journal:  Can Med Assoc J       Date:  1978-03-18       Impact factor: 8.262

7.  Antenatal prophylaxis of Rh isoimmunization: 28-weeks'-gestation service program.

Authors:  J M Bowman; J M Pollock
Journal:  Can Med Assoc J       Date:  1978-03-18       Impact factor: 8.262

8.  [Prevention of anti-Rh immunization].

Authors:  A Jouvenceaux
Journal:  Rev Fr Transfus       Date:  1971-03

9.  Rh-prophylaxis with immunoglobulin anti-D administered during pregnancy and after delivery.

Authors:  M Hermann; H Kjellman
Journal:  Acta Obstet Gynecol Scand Suppl       Date:  1976

10.  Plasma volume changes in pregnancy in Indian and European primigravidae.

Authors:  C J Hutchins
Journal:  Br J Obstet Gynaecol       Date:  1980-07
View more
  3 in total

1.  Incidence of rhesus immunisation after genetic amniocentesis.

Authors:  A Tabor; D Jerne; J E Bock
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-30

Review 2.  The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation.

Authors:  Giancarlo Maria Liumbruno; Angelo D'Alessandro; Federica Rea; Vanessa Piccinini; Liviana Catalano; Gabriele Calizzani; Simonetta Pupella; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2010-01       Impact factor: 3.443

3.  Plasma half-lives and bioavailability of human monoclonal Rh D antibodies BRAD-3 and BRAD-5 following intramuscular injection into Rh D-negative volunteers.

Authors:  J Goodrick; B Kumpel; D Pamphilon; I Fraser; G Chapman; B Dawes; D Anstee
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.